Clay Siegall
Vermögen: 17 Mio $ am 31.05.2026
Vermögen: 17 Mio $ am 31.05.2026
Der Gründer von Seagen Inc., Clay B. Siegall, ist Chairman, President & Chief Executive Officer bei diesem Unternehmen. Dr. Siegall ist außerdem im Vorstand von 5 weiteren Unternehmen. In der Vergangenheit hatte er die Position des Principal Scientist am Bristol-Myers Squibb Pharmaceutical Research Institute inne. Er erwarb einen Bachelor-Abschluss an der University of Maryland und einen Doktortitel an der George Washington University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC. 0,61 % | 27.03.2026 | 690.704 ( 0,61 % ) | 15 Mio $ | 31.05.2026 |
SHATTUCK LABS, INC. 0,42 % | 09.06.2026 | 318.608 ( 0,42 % ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Vorstandsvorsitzender | 02.10.2023 |
| SHATTUCK LABS, INC. | Direktor/Vorstandsmitglied | 01.03.2024 |
Washington Roundtable
Washington Roundtable Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that comprised senior executives of major private sector employers in Washington state | Direktor/Vorstandsmitglied | - |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Vorsitzender | 13.12.2023 |
The Pacific Northwest Research Institute, Inc.
The Pacific Northwest Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization which engages in the biomedical research | Direktor/Vorstandsmitglied | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | 14.12.2012 |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Vorstandsvorsitzender | 01.10.2023 |
| NURIX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.05.2022 |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 17 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Roundtable
Washington Roundtable Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that comprised senior executives of major private sector employers in Washington state | Commercial Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Bristol-Myers Squibb Pharmaceutical Research Institute | |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the development of micro ribonucleic acid based oncology therapeutics | Commercial Services |
The Pacific Northwest Research Institute, Inc.
The Pacific Northwest Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization which engages in the biomedical research | Commercial Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen